Table 3.
Infection | Clone | % with losses or gains | Instability score* | Mitotic delay | Centrosome abnormality† | |
---|---|---|---|---|---|---|
Ch. 11 | Ch. 12 | |||||
LXSN | La | 6% (2)‡ | 5% (2) | 0 (0/10) | Normal | — |
Lb | 5% (2) | 1% (2) | Normal | — | ||
Lc | 8% (2) | 8% (2) | N.D. | — | ||
Ld | 5% (2) | 9% (2) | N.D. | — | ||
Le | 6% (2) | 8% (2) | N.D. | — | ||
HPV16-E6 | Ea | 6% (2) | 3% (2) | 0.1 (1/10) | N.D. | — |
Eb | 5% (2) | 1% (2) | Normal | — | ||
Ec | 2% (2) | 5% (2) | N.D. | — | ||
Ed | 12% (2) | 7% (2) | Normal | — | ||
Ee | 4% (2) | 7% (2) | N.D. | — |
*Fraction of events (i.e., losses or gains compared with modal number of chromosomes) observed in the two infections.
†Determined as described in the footnote of Table 2 ▶ .
‡Numbers in parentheses show modal numbers of each chromosome.